GlassScriptPhysician profile
Anton Dias Perera
NPI 1336313170
$831,792.23
in general payments reported to CMS, 2019-2025
32 companies · $2,008 in 2025
The $2,008 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,035 · 2020: $1,272 · 2021: $413 · 2022: $1,420 · 2023: $1,563 · 2024: $821K · 2025: $2,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $817K · Food and Beverage: $7,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $817,190.00 |
| Food and Beverage | $7,462.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $817,190.00 | 2024 | |
| Medtronic, INC. | $4,239.86 | 2021-2025 | Endurant Iis, Hawkone, Ellipsys Vascular Access System |
| Philips North America LLC | $2,740.15 | 2019-2025 | (Az7) Lasers, Peripheral Vascular Undivided, (Br5) Peripheral Ivus |
| Abbott Laboratories | $1,392.75 | 2019-2025 | Diamondback Peripheral, Esprit, Absolute Pro |
| Endologix LLC | $1,234.41 | 2019 | |
| Medtronic Vascular, INC. | $1,208.86 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $757.29 | 2019-2025 | Gore Excluder Aaa Endoprosthesis |
| Terumo Medical Corporation | $560.72 | 2019-2024 | Angio-Seal |
| Bard Peripheral Vascular, INC. | $541.25 | 2019-2025 | Rotarexs 6 F X 135 Cm, Pristine |
| Angiodynamics, INC. | $278.95 | 2022-2023 | Auryon Laser System 100-120 Vac |
| Becton, Dickinson and Company | $252.67 | 2024-2025 | Lutonix Drug Coated Balloon, Lifestent Solo Vascular Stent, Rotarexs 6 F X 135 Cm |
| Cardiovascular Systems INC. | $229.98 | 2022 | |
| Boston Scientific Corporation | $177.83 | 2019-2025 | Opticross 35 |
| Janssen Pharmaceuticals, INC | $173.37 | 2019-2022 | |
| Penumbra, INC. | $150.15 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argon Medical Devices, INC. | $127.73 | 2023-2024 | Cleaner, Clot Management |
| Smith+Nephew, INC. | $113.20 | 2019 | |
| Cook Medical LLC | $92.16 | 2019-2025 | Zenith Spiral-Z |
| Silk Road Medical, INC. | $49.02 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Lemaitre Vascular, INC. | $44.23 | 2022 | |
| Elutia, INC. | $40.40 | 2019 | |
| Getinge USA Sales, LLC | $34.72 | 2020 | |
| Acera Surgical, INC. | $23.32 | 2019 | |
| Shockwave Medical, INC | $20.73 | 2019 | |
| Baxter Healthcare | $18.73 | 2020 | |
| Osiris Therapeutics INC. | $18.09 | 2019 | |
| Venclose INC. | $17.52 | 2020 | |
| Nuwellis, INC. | $14.68 | 2020 | |
| Hypermed Imaging INC. | $13.51 | 2019 | |
| Misonix INC | $13.22 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.75 | 2020 | |
| Medela LLC | $9.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anton Dias Perera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.